FIELD: medicine, obstetrics, gynecology.
SUBSTANCE: at the background of therapy conducted one should introduce derinate immunomodulator into the body of pregnant woman additionally nasally per 1-2 drops of 0.25%-solution into each nasal canal 5-8 times daily for 3-5 d and - parenterally per 5.0 ml of 1.5%-solution once daily for 3-8 d along with preparation that improves microcirculation and along with antioxidant at a certain sequence, moreover, derinate should be introduced 30-40 min after application of microcirculation-improving preparation, and antioxidant - 20-30 min after derinate's introduction. The present innovation favors decreased edemas, decreased body weight, stabilization of Macluer-Aldrich test that in its turn enables to avoid perinatal losses, decrease the risk for the development of fetoplacental insufficiency and intrauterine fetal infection.
EFFECT: higher efficiency of therapy.
1 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF A PHOSPHOLIPID EMULSION CONTAINING AN EFFECTIVE AMOUNT OF DIHYDROQUERCETIN FOR TREATING GESTOSES OF THE FIRST TRIMESTER OF PREGNANCY | 2021 |
|
RU2773682C1 |
METHOD FOR PROPHYLAXIS OF TARDY TOXICOSES IN PREGNANT WOMEN | 1991 |
|
RU2099066C1 |
METHOD FOR TREATING MILD FORMS OF LATER GESTOSIS | 1998 |
|
RU2180208C2 |
METHOD FOR TREATING PREGNANCY GESTOSIS | 1995 |
|
RU2110228C1 |
METHOD FOR TREATING LIGHT FORMS OF LATE GESTOSIS OF PREGNANT WOMEN | 1997 |
|
RU2154446C2 |
AGENT FOR TREATMENT OF GESTATION PYELONEPHRITIS | 2001 |
|
RU2181293C1 |
METHOD FOR DETERMINING SEVERITY OF GESTOSIS IN PREGNANT WOMEN | 2012 |
|
RU2521359C2 |
METHOD FOR PREVENTING LATE TOXICOSIS OF PREGNANCY | 1995 |
|
RU2129863C1 |
METHOD FOR PREDICTING REPEATED ARRIVAL OF SEVERE GESTOSIS FORMS | 2003 |
|
RU2239839C1 |
METHOD FOR PREDICTING GESTOSIS | 2004 |
|
RU2263913C2 |
Authors
Dates
2005-01-10—Published
2003-08-28—Filed